Fabry disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney function.
Ries
Markus
M
Schiffmann
Raphael
R
D000293:Adolescent; D017677:Age Distribution; D000794:Angiokeratoma / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D015415:Biomarkers / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D016001:Confidence Intervals; D018450:Disease Progression; D000795:Fabry Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011379:Prognosis; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D017678:Sex Distribution; D016896:Treatment Outcome; D014281:Trihexosylceramides / Q000627:therapeutic use
D015415:Biomarkers; D014281:Trihexosylceramides